Filing Details
- Accession Number:
- 0000950170-23-048422
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-15 17:17:35
- Reporting Period:
- 2023-08-23
- Accepted Time:
- 2023-09-15 17:17:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1880438 | An2 Therapeutics Inc. | ANTX | () | E9 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1783165 | Adjuvant Global Health Technology Fund, L.p. | C/O Adjuvant Capital, L.p. 501 Fifth Avenue, Suite 1404 New York NY 10017 | No | No | No | No | |
1799812 | Adjuvant Global Health Technology Fund De, L.p. | C/O Adjuvant Capital, L.p. 501 Fifth Avenue, Suite 1404 New York NY 10017 | No | No | No | No | |
1935084 | Adjuvant Capital Management, Llc | C/O Adjuvant Capital, L.p. 501 Fifth Avenue, Suite 1404 New York NY 10017 | No | No | No | No | |
1935100 | Adjuvant Capital Gp, L.p. | C/O Adjuvant Capital, L.p. 501 Fifth Avenue, Suite 1404 New York NY 10017 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-09-13 | 336 | $16.00 | 2,177,547 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-09-13 | 64 | $16.00 | 411,893 | No | 4 | S | Indirect | By Adjuvant Global Health Technology Fund DE, L.P.( |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | By Adjuvant Global Health Technology Fund DE, L.P.( |
Footnotes
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.
- Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
- Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.